Cargando…
Real-World Utilization of Oral Anticancer Agents and Related Costs in Older Adults with Metastatic Renal Cell Carcinoma in the United States
BACKGROUND: Substantial racial and socioeconomic disparities in metastatic RCC (mRCC) have persisted following the introduction of targeted oral anticancer agents (OAAs). The relationship between patient characteristics and OAA access and costs that may underlie persistent disparities in mRCC outcom...
Autores principales: | Wilson, Lauren E., Spees, Lisa, Pritchard, Jessica, Greiner, Melissa A., Scales, Charles D., Baggett, Christopher D., Kaye, Deborah, George, Daniel J., Zhang, Tian, Wheeler, Stephanie B., Dinan, Michaela A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474520/ https://www.ncbi.nlm.nih.gov/pubmed/34632169 http://dx.doi.org/10.3233/KCA-210119 |
Ejemplares similares
-
Provider‐ and patient‐level predictors of oral anticancer agent initiation and adherence in patients with metastatic renal cell carcinoma
por: Spees, Lisa P., et al.
Publicado: (2021) -
Risk factors for dementia onset in older adults with metastatic renal cell carcinoma
por: Miller, Samuel, et al.
Publicado: (2021) -
Disparities in immune and targeted therapy utilization for older US patients with metastatic renal cell carcinoma
por: Chow, Ryan D, et al.
Publicado: (2023) -
Challenges in Predicting Future Costs for Metastatic Breast Cancer
por: Dinan, Michaela A, et al.
Publicado: (2021) -
Zillow MD: Do housing prices predict cancer survival?
por: Dinan, Michaela A, et al.
Publicado: (2023)